|
Bernal E, Garcia-Villalba E, Pons E, Hernandez MD, Baguena C, Puche G, Carter P, Martinez M, Alcaraz A, Tomas C, Munoz A, Vicente MR, Nunez ML, Sancho N, Villalba MC, Cano A, Minguela A. Remdesivir plus dexamethasone is associated to improvement in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status. Med Clin (Barc). 2023 Aug 25;161(4):139-146. doi: 10.1016/j.medcli.2023.03.025. Epub 2023 Apr 5. PubMed PMID: 37100681; PubMed Central PMCID: PMC10073576.
AÑO: 2023; IF: 2.6
|
37100681
|
Boix F, Jimenez-Coll V, Legaz I, Alfaro R, Moya-Quiles MR, Pena-Moral J, Minguela A, Llorente S, Muro M. Higher Expression of Activated CD8+ T Lymphocytes (CD8+CD25+, CD8+CD69+ and CD8+CD95+) Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients. Front Biosci (Landmark Ed). 2023 Jun 27;28(6):119. doi: 10.31083/j.fbl2806119. PubMed PMID: 37395036.
AÑO: 2023; IF: 3.3
|
|
Jimenez-Coll V, El Kaaoui El Band J, Llorente S, Gonzalez-Lopez R, Fernandez-Gonzalez M, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, Minguela A, Legaz I, Muro M. All That Glitters in cfDNA Analysis Is Not Gold or Its Utility Is Completely Established Due to Graft Damage: A Critical Review in the Field of Transplantation. Diagnostics (Basel). 2023 Jun 6;13(12):1982. doi: 10.3390/diagnostics13121982. PubMed PMID: 37370877; PubMed Central PMCID: PMC10297394.
AÑO: 2023; IF: 3.0
|
|
Alfaro R, Rodriguez-Aguilar L, Llorente S, Jimenez-Coll V, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, Muro-Perez M, Minguela A, Legaz I, Muro M. Early Cytomegalovirus Reactivation in Renal Recipients Is Associated with High Levels of B Cell Maturation Antigen Transcript Expression Prior to Transplantation. Int J Mol Sci. 2023 Jun 22;24(13):10491. doi: 10.3390/ijms241310491. PubMed PMID: 37445668; PubMed Central PMCID: PMC10341624.
AÑO: 2023; IF: 4.9
|
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2024 Jan;26(1):278-287. doi: 10.1007/s12094-023-03251-0. Epub 2023 Jun 27. PubMed PMID: 37368200.
AÑO: 2024; IF: 2.5
|